h1

001016164 001__ 1016164
001016164 005__ 20250909171711.0
001016164 0247_ $$2ISSN$$a0036-553X
001016164 0247_ $$2ISSN$$a0902-4441
001016164 0247_ $$2ISSN$$a1600-0609
001016164 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-105009855712
001016164 0247_ $$2WOS$$aWOS:001523174100001
001016164 0247_ $$2datacite_doi$$a10.18154/RWTH-2025-06779
001016164 0247_ $$2doi$$a10.1111/ejh.70005
001016164 0247_ $$2pmid$$apmid:40619737
001016164 037__ $$aRWTH-2025-06779
001016164 041__ $$aEnglish
001016164 082__ $$a610
001016164 1001_ $$0P:(DE-82)IDM06178$$aKoschmieder, Steffen$$b0$$eCorresponding author$$urwth
001016164 245__ $$aFinal Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical Routine$$honline, print
001016164 260__ $$aOxford$$bWiley-Blackwell$$c2025
001016164 3367_ $$00$$2EndNote$$aJournal Article
001016164 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
001016164 3367_ $$2BibTeX$$aARTICLE
001016164 3367_ $$2DRIVER$$aarticle
001016164 3367_ $$2DataCite$$aOutput Types/Journal article
001016164 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001016164 536__ $$0G:(DE-82)021000-OAPKF$$aOAPKF - Open-Access-Publikation mit Unterstützung der RWTH Aachen University (021000-OAPKF)$$c021000-OAPKF$$x0
001016164 588__ $$aDataset connected to CrossRef, Journals: publications.rwth-aachen.de
001016164 591__ $$aGermany
001016164 7001_ $$0P:(DE-82)136034$$aIsfort, Susanne$$b1$$urwth
001016164 7001_ $$aSchulte, Clemens$$b2
001016164 7001_ $$aJacobasch, Lutz$$b3
001016164 7001_ $$aGeer, Thomas$$b4
001016164 7001_ $$00000-0002-0457-7793$$aReiser, Marcel$$b5
001016164 7001_ $$aKoenigsmann, Michael$$b6
001016164 7001_ $$aHeinrich, Bernhard$$b7
001016164 7001_ $$aWehmeyer, Jürgen$$b8
001016164 7001_ $$avon der Heyde, Eyck$$b9
001016164 7001_ $$aTesch, Hans$$b10
001016164 7001_ $$aGröschl, Benedikt$$b11
001016164 7001_ $$aBachhuber, Petra$$b12
001016164 7001_ $$aGroßer, Susanne$$b13
001016164 7001_ $$aKoehler, Michael$$b14
001016164 7001_ $$aPahl, Heike L.$$b15$$eCorresponding author
001016164 773__ $$0PERI:(DE-600)2027114-1$$a10.1111/ejh.70005$$n4$$p380-390$$tEuropean journal of haematology$$v115$$x1600-0609$$y2025
001016164 8564_ $$uhttps://publications.rwth-aachen.de/record/1016164/files/1016164.pdf$$yOpenAccess
001016164 909CO $$ooai:publications.rwth-aachen.de:1016164$$popenaire$$popen_access$$pdriver$$pdnbdelivery$$pVDB
001016164 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06178$$aRWTH Aachen$$b0$$kRWTH
001016164 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)136034$$aRWTH Aachen$$b1$$kRWTH
001016164 9141_ $$y2025
001016164 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
001016164 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001016164 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J HAEMATOL : 2022$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001016164 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-06
001016164 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2024-12-06$$wger
001016164 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-06
001016164 9201_ $$0I:(DE-82)531040-2_20140620$$k531040-2 ; 933110$$lKlinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)$$x0
001016164 9201_ $$0I:(DE-82)531040-3_20140620$$k531040-3 ; 933210$$lLehr- und Forschungsgebiet Translationale Hämatologie und Onkologie$$x1
001016164 961__ $$c2025-08-11T17:40:29.114608$$x2025-08-11T17:40:29.114608$$z2025-08-11T17:40:29.114608
001016164 9801_ $$aFullTexts
001016164 980__ $$aI:(DE-82)531040-2_20140620
001016164 980__ $$aI:(DE-82)531040-3_20140620
001016164 980__ $$aUNRESTRICTED
001016164 980__ $$aVDB
001016164 980__ $$ajournal